YAP1 and ovarian carcinoma: The transcriptional co-activators YAP and TAZ have been reported to promote ovarian cancer tumorigenesis.399,400 Moreover, mRNA and protein levels of TAZ has been reported to be upregulated in ovarian cancer and a meta-analysis of microarray datasets of ovarian cancer has identified that increased expression of TAZ mRNA is correlated with poor prognosis in patients with ovarian cancer.401 Furthermore, YAP is highly expressed in inflammatory and cancerous fallopian tube tissues and YAP interacts with FGF-FGFR pathway to regulate fallopian tube umbilical epithelial cell activity.